The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Arrowhead Research's new formulation of dynamic polyconjugate (DPC) siRNA delivery system. The patent application No.13/032,029 covers claims for ...
Tags: siRNA delivery system, US Patent, dynamic polyconjugate, DPC platform
Alitair Pharmaceuticals has gained a notice of allowance from the US Patent and Trademark Office for its ion exchange resin platform drug delivery technology, REA. Alitair has out-licensed two product candidates utilizing its REA platform ...
Tags: Alitair Pharmaceuticals, REA Drug Delivery Technology, US Patent
The United States Patent and Trademark Office has granted a second patent notice of allowance for Cumberland Pharmaceuticals' revised formulation of Acetadote (acetylcysteine) injection. Acetadote is a drug used to minimize liver damage ...
Tags: Cumberland Pharmaceuticals, Acetadote(acetylcysteine)injection
The US Patent and Trademark Office(USPTO)has granted a Notice of Allowance(NOA)to Silence Therapeutics for claims related to interfering RNA molecules and lipid complexes used in drug delivery. The NOA,which is issued based on the ...
Tags: Silence Therapeutics, RNAi therapeutics, Silence Company, RNA molecules
The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) for Quick-Med Technologies' patent protecting new antimicrobial technology, Stay Fresh. The active antimicrobial agent utilizes non-toxic hydrogen peroxide ...
Tags: antimicrobial technology, Health
Picomole patent paves way for breath analysis 13 Sep 2012 The company's infrared system for detecting signs of medical conditions in exhaled breath will soon receive US patent approval. Breath test Picomole,a developer of ...
Intematix expects issuance of the patent by the end of the year. Intematix's patent application number 12/632,550,entitled"Nitride-based Red Phosphors"is expected to be the 18th U.S.patent issued to Intematix in the area of LED phosphors ...
Intellect Neurosciences has won a notice of allowance (NOA) from the European Patent Office for its OX1, which has been licensed to ViroPharma for Friedrich's Ataxia and other neurodegenerative diseases. The OX1 patent relates to a new ...
Tags: neurodegenerative disease, patent, notice of allowance
The US Patent and Trademark Office (USPTO) has issued a notice of allowance for CytRx Corporation's patent application covering a pharmaceutical composition of tamibarotene in capsule form. Tamibarotene is an orally available, ...
Tags: notice of allowance, patent application, tamibarotene, USPTO
The United States Patent and Trademark Office (USPTO) has published notification of a notice of allowance for Amarin's patent application titled Highly Stable EPA in a Capsule. A notice of allowance is issued after the USPTO makes a ...
Tags: patent application, USPTO, AMR101
BioLineRx has received two notices of allowance from USPTO for BL-1021, an orally available small molecule for treating neuropathic pain. The first notice of allowance is issued for patent application claiming BL-1021's composition. Once ...
Tags: BL-1021, neuropathic pain, USPTO allowance
Vermillion has received a notice of allowance from the United States Patent and Trademark Office for a patent entitled, Biomarkers for Ovarian Cancer. The patent makes claims in the uses of a urinary Small MBL-associated protein ...
Lixte Biotechnology, a cancer drug discovery company, has received a notice of allowance from the USPTO for its histone deacetylase inhibitor (HDACi), LB-201, and other structural homologs. Lixte founder and president John Kovach said ...
Tags: USPTO, cancer treatment, clinical technology, pharmaceutical product